Cargando…

Prospective evaluation of changes in choroidal vascularity index after half-dose photodynamic therapy versus micropulse laser treatment in chronic central serous chorioretinopathy

PURPOSE: To assess whether treatment of chronic central serous chorioretinopathy (cCSC) with photodynamic therapy (PDT) and high-density subthreshold micropulse laser (HSML) results in choroidal vascularity index (CVI) changes that may account for the treatment effect. METHODS: Patients with cCSC we...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Rijssen, Thomas J., Singh, Sumit Randhir, van Dijk, Elon H. C., Rasheed, Mohammed A., Vupparaboina, Kiran Kumar, Boon, Camiel J. F., Chhablani, Jay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Retinal Disorders
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237528/ https://www.ncbi.nlm.nih.gov/pubmed/32170365 http://dx.doi.org/10.1007/s00417-020-04619-6

Ejemplares similares

Outcome of half-dose photodynamic therapy in chronic central serous chorioretinopathy with fovea-involving atrophy
por: van Rijssen, Thomas J., et al.
Publicado: (2020)

Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy
por: van Rijssen, Thomas J., et al.
Publicado: (2018)

Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment: SPECTRA trial report No. 3
por: Feenstra, Helena M. A., et al.
Publicado: (2022)

Fundus autofluorescence abnormalities can predict fluorescein angiography abnormalities in patients with chronic central serous chorioretinopathy
por: Mohabati, Danial, et al.
Publicado: (2023)

Functional and morphological outcome in patients with chronic central serous chorioretinopathy treated by subthreshold micropulse laser
por: Gawęcki, Maciej, et al.
Publicado: (2017)

The spectrum of polypoidal choroidal vasculopathy in Caucasians: clinical characteristics and proposal of a classification
por: van Dijk, Elon H. C., et al.
Publicado: (2020)

Optical coherence tomography angiography–guided vs indocyanine green angiography–guided half-dose photodynamic therapy for acute central serous chorioretinopathy: 6-month randomized trial results
por: Li, Siying, et al.
Publicado: (2023)

Long‐term follow‐up of chronic central serous chorioretinopathy after successful treatment with photodynamic therapy or micropulse laser
por: van Rijssen, Thomas J., et al.
Publicado: (2021)

Subthreshold laser therapy with a standardized macular treatment pattern in chronic central serous chorioretinopathy
por: Schworm, Benedikt, et al.
Publicado: (2021)

Photodynamic therapy in chronic central serous chorioretinopathy with subretinal fluid outside the fovea
por: van Dijk, Elon H. C., et al.
Publicado: (2017)

Change in choroidal vascularity in acute central serous chorioretinopathy
por: Rasheed, Mohammed Abdul, et al.
Publicado: (2018)

INCREASING EVIDENCE FOR THE SAFETY OF FOVEA-INVOLVING HALF-DOSE PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY
por: Feenstra, Helena M. A., et al.
Publicado: (2023)

Correlation between redefined optical coherence tomography parameters and best-corrected visual acuity in non-resolving central serous chorioretinopathy treated with half-dose photodynamic therapy
por: van Rijssen, Thomas J., et al.
Publicado: (2018)

Evaluation of Choroidal Layer Thickness in Central Serous Chorioretinopathy
por: Hanumunthadu, Daren, et al.
Publicado: (2019)

Selective retina therapy (SRT) in patients with therapy refractory persistent acute central serous chorioretinopathy (CSC): 3 months functional and morphological results
por: Büttner, Maximilian, et al.
Publicado: (2020)

Retinal and choroidal changes in steroid-associated central serous chorioretinopathy
por: Ambiya, Vikas, et al.
Publicado: (2018)

Clinical spectrum of severe chronic central serous chorioretinopathy and outcome of photodynamic therapy
por: Mohabati, Danial, et al.
Publicado: (2018)

Water-Drinking Test in Central Serous Chorioretinopathy
por: Goud, Abhilash, et al.
Publicado: (2021)

Comparison of 3-year outcomes of photodynamic therapy combined with intravitreal ranibizumab or aflibercept for polypoidal choroidal vasculopathy in a European cohort
por: Liu, Siyin, et al.
Publicado: (2022)

Current Choroidal Imaging Findings in Central Serous Chorioretinopathy
por: Nkrumah, Gideon, et al.
Publicado: (2020)

Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): study protocol for a randomized controlled trial
por: Breukink, Myrte B., et al.
Publicado: (2015)

Subthreshold micropulse laser photocoagulation versus half-dose photodynamic therapy for acute central serous chorioretinopathy
por: Zeng, Miao, et al.
Publicado: (2022)

Central serous chorioretinopathy in active endogenous Cushing’s syndrome
por: Brinks, Joost, et al.
Publicado: (2021)

Choroidal Vascularity Map in Unilateral Central Serous Chorioretinopathy: A Comparison with Fellow and Healthy Eyes
por: Sahoo, Niroj Kumar, et al.
Publicado: (2021)

Choroidal arteriovenous anastomoses: a hypothesis for the pathogenesis of central serous chorioretinopathy and other pachychoroid disease spectrum abnormalities
por: Brinks, Joost, et al.
Publicado: (2022)

Choroidal thickness in lamellar macular holes
por: Kal, Magdalena, et al.
Publicado: (2020)

Near-infrared reflectance imaging of neovascular age-related macular degeneration
por: Theelen, Thomas, et al.
Publicado: (2009)

Stress and vision-related quality of life in acute and chronic central serous chorioretinopathy
por: Kumar, Meenakshi, et al.
Publicado: (2020)

Biomarkers for central serous chorioretinopathy
por: Nkrumah, Gideon, et al.
Publicado: (2020)

Choroidal Vascularity Index versus Choroidal Thickness as Biomarkers of Acute Central Serous Chorioretinopathy
por: Ruiz-Moreno, José M., et al.
Publicado: (2023)

SINGLE-SESSION BILATERAL REDUCED-SETTINGS PHOTODYNAMIC THERAPY FOR BILATERAL CHRONIC CENTRAL SEROUS CHORIORETINOPATHY
por: Pauleikhoff, Laurenz J.B., et al.
Publicado: (2023)

Clinical characteristics and long-term visual outcome of severe phenotypes of chronic central serous chorioretinopathy
por: Mohabati, Danial, et al.
Publicado: (2018)

Estimation of current and post-treatment retinal function in chronic central serous chorioretinopathy using artificial intelligence
por: Pfau, Maximilian, et al.
Publicado: (2021)

Choroidal Structure after Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy
por: Alovisi, Camilla, et al.
Publicado: (2020)

Investigation of precursor lesions of polypoidal choroidal vasculopathy using contralateral eye findings
por: Kang, Se Woong, et al.
Publicado: (2016)

The association of polypoidal choroidal vasculopathy clinical phenotypes with previously reported genetic markers
por: Luo, Mingyue, et al.
Publicado: (2020)

Sex Hormones in Males and Females with Active Central Serous Chorioretinopathy
por: Brinks, Joost, et al.
Publicado: (2023)

Central serous chorioretinopathy in primary hyperaldosteronism
por: van Dijk, Elon H. C., et al.
Publicado: (2016)

Efficacy of fixed-dosing aflibercept for treating polypoidal choroidal vasculopathy: 1-year results of the VAULT study
por: Lee, Joo Eun, et al.
Publicado: (2016)

Short-term choroidal vascular changes after aflibercept therapy for neovascular age-related macular degeneration
por: Pellegrini, Marco, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3r1rd1h3dmbgilhvuc6s6606eo